Mexico demands Boehringer Ingelheim/Sanofi animal health divestitures

European drugmakers Boehringer Ingelheim and Sanofi will have to sell five animal health vaccines to an approved third-party purchaser in Mexico to clear one of the few remaining antitrust hurdles facing the €22.8 billion asset swap.

Get unlimited access to all Global Competition Review content